CVS HEALTH
DC · US
Tracked giving exceeds tracked receipts by
$575,000
Leading pharmacy benefits and service provider.
Tracked direct giving
$575,000
Tracked donations to candidate
$0
LDA reported lobbying spend
$1,940,000
Connections
16
How money flowed from CVS HEALTH
CVS HEALTH directed $1.7M to Congressional Leadership Fund across 6 contributions between November 2023 and August 2024. CVS HEALTH advocates for Insulin Price Caps - State-Level Legislation.
Where CVS HEALTH’s money ended up
Attributed amounts are modeled estimates of how money flowed through intermediary PACs, computed by proportional apportionment of FEC-reported transactions. They are not reported transactions themselves. How we compute this
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 3 more paths
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 1 more path
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 2 more paths
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 2 more paths
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 3 more paths
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 1 more path
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $399K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
at least $500K documented end-to-end
+ 1 more path
Plus 42 additional chains totaling $265K.
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
Lobbying Firms Retained
Bills Referenced in Lobbying Filings
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Click a node to see details
Double-click to expand its connections
Donations Given
| Recipient | Amount | Date | Cycle |
|---|---|---|---|
| Congressional Leadership Fund | $500,000 | Aug 26, 2024 | 2024 |
| Congressional Leadership Fund | $75,000 | Nov 27, 2023 | 2024 |
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | KOUNTOUPES DENHAM CARR & REID, LLC | Hired KOUNTOUPES DENHAM CARR & REID, LLC to lobby on Insurance / Health Plans | Source |
| Lobbied for | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $80,000 | Source |
| Employed by | BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | Hired BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ to lobby on PBM Reform Act | Source |
| Employed by | KLEIN/JOHNSON GROUP | Hired KLEIN/JOHNSON GROUP to lobby on Insulin Price Caps | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0311: Patient Protection and Affordable Care Act: Notice of Benefit and Payment Parameters for 2026 and Basic Health Program | Source |
| Lobbied for | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $70,000 | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Employed by | KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS | Hired KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | MILLER & CHEVALIER, CHTD | Hired MILLER & CHEVALIER, CHTD to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | AKIN GUMP STRAUSS HAUER & FELD | Hired AKIN GUMP STRAUSS HAUER & FELD to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | ALSTON & BIRD LLP | Hired ALSTON & BIRD LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | CONTINENTAL STRATEGY, LLC | Hired CONTINENTAL STRATEGY, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025) | Source |
| Employed by | MICHAEL BEST STRATEGIES LLC | Hired MICHAEL BEST STRATEGIES LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026) | Source |
| Parent of | Aetna | Aetna is a subsidiary of CVS Health, acquired in 2018 | Source |
| Parent of | Aetna Inc | Aetna is a subsidiary of CVS Health, acquired in 2018 | Source |
| Parent of | CVS Health (Aetna parent) | Aetna is a subsidiary of CVS Health, acquired in 2018 | Source |